IndraLab

Statements

SB 203580 inhibits MAP3K7. 3 / 3
| 1 2
reach
"Of interest, the p38 pathway inhibitor, SB203580, enhanced the antiviral effect of TAK1 on HBV replication (XREF_FIG, lane 6), consistent with a previous publication indicating that suppression of MAPK-p38 inhibits hepatitis B virus replication in human hepatoma cells XREF_BIBR."
28045080
reach
"5Z-7-oxozeaenol and SB203580, which block TAK1 and p38 kinase respectively, abrogated the LTB4 inhibitory effect on L-type calcium channels."
26584289
eidos
"Moreover , the selective protein kinase inhibitors ( 5Z ) -7 - oxozeaenol , U0126 , and SB203580 , which inhibit TAK1 , ERK , and p38 MAPK , respectively , significantly decreased the inductive effect of IL-1beta on IL33 mRNA and IL-33 protein in human ADSCs ( Figures 6D and 6E ) ."
33997712